Previous 10 | Next 10 |
home / stock / sfosf / sfosf news
The head of the American Chamber of Commerce in Shanghai tells Bloomberg that that Chinese government is set to approve the BioNTech (BNTX) COVID-19 vaccine in June.The comments from Ker Gibbs echo a report last week in The Wall Street Journal.Shanghai Fosun Pharmaceutical (SFOSF) will ...
China is on track to approve its first foreign COVID-19 vaccine -- from BioNTech (BNTX) -- within the next 10 weeks, The Wall Street Journal reports.In December, BioNTech reached an agreement with Shanghai Fosun Pharmaceutical (SFOSF) to supply 100M doses to China this year.The newspaper repo...
Shanghai Fosun Pharmaceutical (SFOSF): FY net profit RMB3.66BRevenue of RMB30.31BShares -1.47%.Press Release For further details see: Shanghai Fosun Pharmaceutical reports FY results
On December 16, Fosun and BioNTech announced the formation of a strategic alliance for marketing BioNtech's Covid 19-vaccine in China, Hong Kong, Taiwan and Macao. Under the agreement, BioNTech has committed to supply at least 100 million doses to Fosun in 2021, with preparations repo...
DXY.cn, a China healthcare platform, raised $500 million in an E round. Zai Lab in-licensed China rights to a next-gen EGFR inhibitor aimed at cells expressing mutant EGFR variants from Boston's Cullinan Oncology in an agreement worth up to $233 million. Hutchison China MediTech a...
Overland Pharmaceuticals will form a $117 million China JV with Allogene Therapeutics to bring allogenic CAR-T drugs to China. Harbour BioMed has out-licensed its fully human SARS-CoV-2 neutralizing antibody, 47D11, to AbbVie. Legend Biotech was cleared to start a US Phase I trial...
BioNTech (BNTX) and Shanghai Fosun Pharmaceutical (SFOSF) announce an agreement to supply an initial 100M doses of their mRNA-based COVID-19 vaccine, BNT162 TO Mainland China in 2021, subject to regulatory approval.Initial supply will be delivered from BioNTech’s production facilities ...
CANbridge Pharma completed a $43 million Series E financing that is a follow-on to its $98 million Series D round, announced in February. Pfizer and Germany's BioNTech announced their partnered mRNA COVID-19 vaccine has been approved for use in the UK, the first acceptance of a corona...
The whole world is coming together go fight the invisible enemy called COVID-19. Moreover, the quest for a vaccine is revolutionizing the controversial Big Pharma. Nearly 200 are in development, 39 in human clinical trials and nine in Phase III trials. That is quite something, especially co...
10x Genomics acquired ReadCoor, a Boston developer of In Situ technologies, for $350 million. Corvus Pharma formed a China subsidiary, Angel Pharma, to develop its three clinical-stage assets and one preclinical platform in China. Zai Lab of Shanghai has dosed the first patient in...
News, Short Squeeze, Breakout and More Instantly...
Shanghai Fosun Pharmaceutical Co. Ltd. Company Name:
SFOSF Stock Symbol:
OTCMKTS Market:
The whole world is coming together go fight the invisible enemy called COVID-19. Moreover, the quest for a vaccine is revolutionizing the controversial Big Pharma. Nearly 200 are in development, 39 in human clinical trials and nine in Phase III trials. That is quite something, especially co...
Since the beginning of the pandemic, AstraZeneca (NYSE:AZN) was among the likely winners in the COVID-19 vaccine race. The company has joined forces with the University of Oxford to develop its candidate, AZD1222. But investors recently got a bitter reminder of the difficulties and risks of clin...
Fosun Pharma donates antimalarial medicines to Zambia Ministry of Health and its platform, Chongqing Pharmaceutical Research Institute Co., Ltd., received funding from the Bill & Melinda Gates Foundation to research and develop a large scale semi-synthetic artemisinin process HONG KONG, ...